This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dezzutti, C. S. Articles by Lal, R. B. Search for Related Content PubMed PubMed Citation Articles by Dezzutti, C. S. Articles by Lal, R. B.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 05 1995, 349-355, Vol 2, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T- cell counterreceptors CD40, CD54, and CD80 (B7-1)

CS Dezzutti, DL Rudolph and RB Lal
Retrovirus Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

To examine the phenotypic alterations associated with human T- lymphotropic virus types I and II (HTLV-I and -II) infection, long-term cell lines (n = 12 HTLV-I cell lines; n = 11 HTLV-II cell lines; n = 6 virus-negative cell lines) were analyzed for the cell surface expression of various lineage markers (i.e., myeloid, progenitor, and leukocyte), integrin receptors, and receptor-counterreceptor (R-CR) pairs responsible for cellular activation. As expected, all cell lines expressed the markers characterizing the leukocyte lineage (CD43, CD44, and CD53). Of the progenitor-myeloid markers examined (CD9, CD13, CD33, CD34, and CD63), only the percent expression of CD9 was significantly increased on HTLV-I and -II-infected cell lines as compared with that on virus-negative cell lines. Analysis of the beta 1 integrin subfamily (CD29, CD49b, CD49d, CD49e, and CD49f) showed no significant change, except that CD49e was significantly decreased on the HTLV-infected cell lines. For the beta 2 integrin subfamily, the cell surface density was increased for CD18 and CD11a, while the CD11c molecule was expressed exclusively on the HTLV-I- and HTLV-II-infected cell lines. Analysis of several R-CR pairs (CD2-CD58, CD45RO-CD22, CD5-CD72, CD11a-CD54, gp39- CD40, and CD28-CD80) demonstrated that comparable levels of expression of the Rs (CD2, CD45RO, CD5, and CD28) and of some of the CRs (CD58, CD22, and CD72) were in all cell lines; however, CD54, CD40, and CD80 were expressed constitutively on the HTLV-I- and HTLV-II-infected cell lines.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

• Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Takemura, F., Hirokawa, K., Yoshiki, T., Yagita, H., Okumura, K., Kannagi, M. (2000). Development of Human T-Cell Leukemia Virus Type 1-Transformed Tumors in Rats following Suppression of T-Cell Immunity by CD80 and CD86 Blockade. J. Virol. 74: 428-435 [Abstract] [Full Text]  
• Mulloy, J. C., Migone, T.-S., Ross, T. M., Ton, N., Green, P. L., Leonard, W. J., Franchini, G. (1998). Human and Simian T-Cell Leukemia Viruses Type 2 (HTLV-2 and STLV-2pan-p) Transform T Cells Independently of Jak/STAT Activation. J. Virol. 72: 4408-4412 [Abstract] [Full Text]